Guidance

Release of veterinary medicinal products to the market (VMGN 18)

Veterinary medicines guidance note for holders of marketing authorisations (MAs) and autogenous vaccine authorisations (AVAs) on batch release schemes.

Document

Detail

The batch release scheme relates to authorised Immunological Veterinary Medicinal Products (IVMPs) which cannot be placed onto the UK market without a batch release request submitted to the Veterinary Medicines Directorate (VMD).

The specific batch control scheme relates to authorised veterinary pharmaceuticals, which can be released onto the market without the requirement to inform the VMD if there is an MA for the medicine.